X

Ganesh Benzoplast Ltd. Stock Analysis

Small Cap
Evaluated by 402 users | BSE: 500153 | NSE: GANESHBENZ |
Chemicals
Ganesh Benzoplast was established in 1974. It has 34 years of experience which assists it in offering top quality specialty chemicals, drug intermediates, pharmaceutical intermediates, bulk drug intermediates such as sodium benzoate, benzoic acid, ferrous fumarate, phenobarbitone, petroleum...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Capital Employed -04.71%6.17%9.61%5.05%5.8%14.91%16.01%31.4%23.58%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 71.595.9102118115122119118169212
Y-o-Y Gr. Rt.-34.3%6.4%16%-2.5%6%-2.3%-1.1%43.2%25.1%
Adjusted EPS (Rs.) -2.39-0.090.221.690.050.022.62.768.226.47
Y-o-Y Gr. Rt.-NANA668.2%-97%-60%12900%6.2%197.8%-21.3%
Book Value per Share (Rs.) -21.05-18.31-18.08-16.39-16.37-16.38-7.08-4.6215.4821.53
Adjusted Net Profit -11.5-0.41.18.80.30.113.514.342.633.5
Net Op. Cash Flow (Rs. Cr.) 22.925.527.536.725.92741.836.439.360.7
Debt to Cash Flow from Ops 12.7811.2610.457.6410.549.414.654.882.191.09
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Ganesh Benzoplast Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 12.8%12.9%21%25.1%
Adjusted EPS NA164.5%35.5%-21.3%
Book Value per Share 00039.1
Share Price 29.6% 44.1% -8.9% 105.3%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Equity (%) 10.230.45-1.22-9.86-0.31-0.1-22.39-47.96148.4934.77
Operating Profit Margin (%) 29.8631.3131.932.8325.5912.1431.3331.9330.5726.51
Net Profit Margin (%) -16.14-0.461.127.390.230.0711.2912.0825.1515.83
Debt to Equity -2.9-3.04-3.08-3.33-3.24-3.01-5.37-7.591.070.59
Working Capital Days 183147159178225224199190159127
Cash Conversion Cycle -48-46-46-52-62-79-127-146-104-75
Entity Percentage Holding
Promoters 43.33%
Institutions 0.45%
Non-Institutions 56.22%
Pledged *80.2981.1982.0882.0878.8876.8065.4564.5664.560.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Ganesh Benzoplast Ltd.'s performance infers:

Ganesh Benzoplast Ltd. earnings have grown by 164.5%, whereas share price has appreciated 44.1% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Ganesh Benzoplast Ltd. share prices over the last 10 years. Here is what we found out:

Ganesh Benzoplast Ltd. share price has appreciated 24.3% annually over the past ten years.

Ganesh Benzoplast was established in 1974. It has 34 years of experience which assists it in offering top quality specialty chemicals, drug intermediates, pharmaceutical intermediates, bulk drug intermediates such as sodium benzoate, benzoic acid, ferrous fumarate, phenobarbitone, petroleum sulphonates, lubricant additives and components. The range is quality-tested on various parameters in compliance with international standards as well as in accordance with emerging needs of our

Ganesh Benzoplast was established in 1974. It has 34 years of experience which assists it in offering top quality specialty chemicals, drug intermediates, pharmaceutical intermediates, bulk drug intermediates such as sodium benzoate, benzoic acid, ferrous fumarate, phenobarbitone, petroleum sulphonates, lubricant additives and components. The range is quality-tested on various parameters in compliance with international standards as well as in accordance with emerging needs of our clients.

Business area of the company:

The company is engaged in the manufacturing and exporting of drug intermediates, pharmaceutical intermediates, bulk drug intermediates, food preservatives, lubricants, API/bulk drug, etc.

Product offered by the company:

  • Food preservatives
  • Petroleum sulphonates
  • Lubricant additives
  • Lubricant components
  • API/ bulk drug
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback